Archive for July, 2017

Recent Rosacea Blog Posts

Soolantra worth $87m in the last year

One thing we have learned from the news that Perrigo and Galderma are embarking on a patent dispute, is how successful Soolantra has been as a product. Perrigo Confirms Patent Challenge For Generic Version Of Soolantra Cream, 1% Soolantra (ivermectin) cream, 1% is indicated for the treatment of inflammatory lesions of rosacea. Annual market sales […]

Continue Reading

Rosacea means drier, redder and sweaty skin

This paper is full of technical terms, but contains some simply stated outcome for rosacea suffers. Researchers can see that rosacea sufferers have more water loss from the surface of their skin (i.e. their skin gets drier and potentially more irritated) , greater dilation of blood vessels and more rapid sweating than the general population. […]

Continue Reading

Soolantra is both anti-inflammatory and anti-demodex

This paper is exploring the reasons for Soolantra’s success in treating the lumps and bumps of rosacea; its dual method of action – both as an antiparasitic and anti-inflammatory. The research was able to show that along with the improvement in rosacea symptoms, trialists had a significant reduction in the amount of demodex mites present […]

Continue Reading

If you live in the San Diego area and qualify you may be interested in the following clinical trial that is recruiting participants. A Rosacea study is for a topical minocycline foam and qualifying criteria are as follows: > 18 years of age male and females Moderate to severe rosacea (15-75 facial papules and pustules […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.